Archives
-
Berberine Hydrochloride: AMPK Assay Strategy
2026-08-22
Berberine hydrochloride is a versatile probe for AMPK, lipid metabolism, apoptosis, and ferroptosis research. This guide uses a cardiotoxicity study to show how pathway-focused assays can improve experimental interpretation and reproducibility.
-
Tomivosertib in Acute Myeloid Leukemia Research
2026-08-21
Suarez and colleagues evaluated the highly selective MNK1/2 inhibitor Tomivosertib in acute myeloid leukemia models, linking suppression of eIF4E Ser209 phosphorylation to reduced leukemic cell viability and progenitor colony formation. The study also identified synergistic activity with Venetoclax and used mass spectrometry to expand the map of candidate MNK1/2-associated proteins, while showing that MNK2–RAPTOR–mTOR complexes were not disrupted by treatment.
-
Angiotensin I: Reliable Assay Workflows
2026-08-20
Learn how Angiotensin I (human, mouse, rat), SKU A1006, can improve control of peptide identity, formulation, dosing, and interpretation in viability, proliferation, and cytotoxicity workflows. The article connects product specifications with renin–angiotensin system research and recent angiotensin-peptide binding data while defining practical experimental limits.
-
PP 1: Src Family Tyrosine Kinase Workflows
2026-08-20
PP 1 enables controlled dissection of Lck, Fyn, Lyn, and RET-associated signaling in cancer and immunology models. This practical guide pairs concentration-aware kinase workflows with multimodal assay logic inspired by recent gastric cancer radiopathomics research.
-
Oleanolic Acid in Dual-Loaded Liposomes
2026-08-19
Use Oleanolic acid as a lipophilic payload in dual-loaded liposome studies that connect formulation quality with immune-pathway assays. A nanoparticle exclusion chromatography workflow can simplify simultaneous encapsulation-efficiency testing when hydrophilic and lipophilic cargoes are combined.
-
BV6 IAP Antagonist: Applied Assay Workflows
2026-08-19
BV6 is a Smac-mimetic IAP antagonist for testing apoptosis, radiotherapy response, chemotherapy sensitization, and immune-cell cytotoxicity in controlled research models. This guide translates its mechanism into practical dosing, endpoint selection, combination designs, and troubleshooting strategies while separating established evidence from exploratory workflows.
-
Tomivosertib: Selective MNK1 Inhibitor Guide
2026-08-18
Tomivosertib is a potent, orally active MNK1 inhibitor that also targets MNK2 and suppresses eIF4E Ser209 phosphorylation. Its research applications include acute myeloid leukemia, glioblastoma, neuronal excitability, hepatic metabolism, angiogenesis, and pancreatic tumor models.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-08-18
Zhang et al. show that CDC42-dependent apical–basal polarity controls the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ–Ereg–mTOR cascade that operates independently of canonical Wnt signaling. The study connects epithelial architecture with crypt proliferation and provides a genetic and pharmacological framework for dissecting intestinal epithelial homeostasis.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-17
The reference study used voltage-clamped frog nerve fibers to show that Halazone and hypochlorous acid strongly disrupt sodium-current inactivation, whereas several other oxidants and residue-selective reagents produced different or weaker effects. Its comparative design argues against a uniquely critical methionine residue and supports membrane-lipid modification as a plausible explanation, while also defining important limits for translating neurophysiological findings to water disinfection.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-17
A 2025 study identifies social interaction-induced cleavage of Neuroligin 1 as a mechanism supporting short-term social memory maintenance in the ventral hippocampus. The resulting NLG1-CTD fragment links secretase activity to cofilin-dependent synaptic remodeling, while peptide rescue experiments provide a potential framework for studying memory-maintenance defects.
-
Renal Blood Flow, Sepsis, and K+ Channel Blockade
2026-08-16
The reference study examined how potassium-channel blockade changes renal vascular responses to norepinephrine and phenylephrine in septic rats. Its central finding is that blocking Kir6.1 or KCa1.1 channels can worsen pressor-associated renal hypoperfusion, emphasizing that systemic vasopressor effects cannot be inferred from baseline renal blood flow alone.
-
Dacomitinib: From ErbB Blockade to Ferroptosis
2026-08-15
Dacomitinib (PF-00299804) offers a rigorous way to study irreversible ErbB signaling blockade, apoptosis, and treatment resistance. This article develops a distinct assay framework connecting receptor inhibition with mitochondrial ferroptosis biology while separating validated evidence from exploratory hypotheses.
-
Oligomycin A: An Energy-Failure Assay Framework
2026-08-14
Oligomycin A is a mitochondrial ATP synthase inhibitor that can reveal how respiratory ATP failure reshapes cell fate. This article develops a decision framework linking ATP synthase perturbation with sodium-driven mitochondrial dysfunction while clarifying what the assay can—and cannot—prove.
-
H-89 for PKA Control in Wnt–Bone Metabolism Studies
2026-08-14
H-89 provides a reversible way to test whether PKA contributes to the rapid, metabolic arm of Wnt signaling in osteoblast and MSC models. This workflow separates early cAMP–PKA–O-GlcNAc responses from later β-catenin-associated effects while adding practical controls for cell proliferation, apoptosis, and metabolic readouts.
-
Molidustat (BAY85-3934) Experimental Workflows
2026-08-13
Build practical HIF stabilization and erythropoietin stimulation assays with Molidustat (BAY85-3934), from biochemical potency testing to hypoxic cardiomyocyte models. The workflow connects renal anemia research with VHL-mediated HIF-1α degradation while clearly separating established evidence from experimental extensions.